Brian Loftus
Neurology · Bellaire, TXNPI 1912983511
Payments from drug & device makers
Across 587 payments — averaging $329.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$60K
- AbbVie$43K
- Impel Pharmaceuticals Inc.$19K
- Biohaven Pharmaceutical Holding Company Ltd.$16K
- Lundbeck LLC$15K
- Amgen$13K
- plus $27K from 27 others
What the payments were for
- Consulting fees$36,61419%
- Speaking & faculty fees$133,80069%
- Travel & lodging$9,2495%
- Food & beverage$13,6007%
- Education$2750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 107 | $59,785 |
| AbbVie(2 entities) | 103 | $42,506 |
| Impel Pharmaceuticals Inc. | 32 | $18,800 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $16,414 |
| Lundbeck LLC | 48 | $15,305 |
| Amgen | 33 | $13,394 |
| Biodelivery Sciences International, Inc. | 15 | $10,287 |
| Biohaven Pharmaceuticals, Inc. | 15 | $9,995 |
| Pfizer | 19 | $1,304 |
| Novartis | 58 | $1,176 |
| Collegium Pharmaceutical, Inc. | 5 | $1,000 |
| Biogen | 20 | $766 |
| Lilly USA, LLC | 25 | $696 |
| SK Life Science, Inc. | 17 | $411 |
| Neurelis, Inc. | 13 | $331 |
| Genentech USA, Inc. | 12 | $234 |
| TG Therapeutics, Inc. | 3 | $232 |
| EMD Serono, Inc. | 9 | $170 |
| Scilex Pharmaceuticals Inc. | 7 | $136 |
| Boston Scientific | 1 | $119 |
| Impel Pharmaceuticals LLC | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Livanova USA, Inc. | 3 | $55 |
| Tonix Medicines, Inc. | 2 | $44 |
| GRT US Holding, Inc. | 2 | $44 |
| Currax Pharmaceuticals LLC | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Greenwich Biosciences, Inc. | 2 | $27 |
| Avanir Pharmaceuticals, Inc. | 2 | $25 |
| Merz North America, Inc. | 1 | $24 |
| Medtronic | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$58,350
- UBRELVY$40,016
- NURTEC ODT$26,685
- Trudhesa$18,420
- VYEPTI$14,190
- AIMOVIG$12,759
- ELYXYB - CELECOXIB$10,821
- BOTOX$727
- QULIPTA$524
- TYSABRI$450
- BRIUMVI$120
- KISUNLA$119
- SPECTRA WAVEWRITER$119
How this compares
$193,538 in reported general payments places this provider in the 85th percentile of 1,246 neurology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XcopriCenobamate | 40 | $62,656 |
| Aimovig AutoinjectorErenumab-Aooe | 53 | $46,011 |
| Nurtec OdtRimegepant Sulfate | 19 | $29,325 |
| Emgality SyringeGalcanezumab-Gnlm | 20 | $26,906 |
| Emgality PenGalcanezumab-Gnlm | 25 | $22,457 |
| QuliptaAtogepant | 14 | $17,927 |
| BotoxOnabotulinumtoxina | 11 | $13,772 |
| Sumatriptan Succinate | 73 | $6,825 |
| Zolmitriptan | 11 | $6,738 |
| Lacosamide | 40 | $6,634 |
| Pregabalin | 21 | $4,646 |
| Divalproex Sodium | 26 | $2,871 |
| Tiagabine Hcl | 13 | $2,827 |
| Zonisamide | 90 | $2,685 |
| Felbamate | 13 | $2,677 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $411 | $62,65640 claims |
| AbbVieQulipta, Botox | $42,506 | $31,69925 claims |
| PfizerNurtec Odt | $1,304 | $29,32519 claims |
| Upsher-smith Laboratories LLCTopiramate | $16 | $71450 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,246 neurology providers in Texas.
Other neurology in Bellaire
- Ann BassSan Antonio$12.3M
- Kandasami SenthilkumarBeaumont$7.6M
- Bharathy SundaramSherman$7.2M
- Bhupesh DiheniaLubbock$6.9M
- Jamshid LotfiHouston$6M
- Nazanin MajdHouston$5.9M
- Aziz ShaibaniHouston$5.5M
- Elizabeth PeckhamRound Rock$5.4M
- Susan IannacconeDallas$5.1M
- Benjamin GreenbergDallas$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.